Mereo BioPharma Group PLC ADR Net Asset Quality Index
Mereo BioPharma Group PLC ADR net asset quality index. Mereo BioPharma Group PLC ADR (MREO) has a Net Asset Quality Index of 82.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $34.71 Million minus total liabilities of $6.06 Million yields net assets of $28.65 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Mereo BioPharma Group PLC ADR (MREO) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Mereo BioPharma Group PLC ADR (2015–2025)
Net asset quality index of Mereo BioPharma Group PLC ADR from 2015 to 2025. This chart shows how Mereo BioPharma Group PLC ADR's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the index stands at 82.5%, representing net assets of $28.65 Million against total assets of $34.71 Million USD. Check how strategically is Mereo BioPharma Group PLC ADR's equity deployed to assess the company's strategic physical and investment asset allocation.
Mereo BioPharma Group PLC ADR Net Asset Quality Index by Year (2015–2025)
Mereo BioPharma Group PLC ADR net asset quality index by year from 2015 to 2025. The table below presents the year-by-year Net Asset Quality Index for Mereo BioPharma Group PLC ADR from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Mereo BioPharma Group PLC ADR.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.1% | $40.92 Million | $45.92 Million | $5.00 Million | ▲ +9.3 pp |
| 2024 | 79.8% | $60.97 Million | $76.39 Million | $15.42 Million | ▲ +3.8 pp |
| 2023 | 76.0% | $50.54 Million | $66.50 Million | $15.96 Million | ▲ +9.6 pp |
| 2022 | 66.4% | $51.40 Million | $77.41 Million | $26.01 Million | ▼ -3.2 pp |
| 2021 | 69.6% | $119.01 Million | $170.96 Million | $51.95 Million | ▲ +93.4 pp |
| 2020 | -23.8% | $-20.47 Million | $86.08 Million | $106.55 Million | ▼ -70.3 pp |
| 2019 | 46.6% | $53.33 Million | $114.52 Million | $61.19 Million | ▼ -2.1 pp |
| 2018 | 48.7% | $32.77 Million | $67.28 Million | $34.51 Million | ▼ -16.1 pp |
| 2017 | 64.9% | $62.48 Million | $96.34 Million | $33.85 Million | ▼ -26.5 pp |
| 2016 | 91.3% | $79.26 Million | $86.76 Million | $7.51 Million | ▼ -3.3 pp |
| 2015 | 94.6% | $101.54 Million | $107.30 Million | $5.76 Million | — |